Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma

73Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Temozolomide (TMZ) is widely used for treating glioblastoma multiforme (GBM), however, the treatment of such brain tumors remains a challenge due to the development of resistance. Increasing studies have found that TMZ treatment could induce autophagy that may link to therapeutic resistance in GBM, but, the precise mechanisms are not fully understood. Understanding the molecular mechanisms underlying the response of GBM to chemotherapy is paramount for developing improved cancer therapeutics. In this study, we demonstrated that the loss of DOC-2/DAB2 interacting protein (DAB2IP) is responsible for TMZ-resistance in GBM through ATG9B. DAB2IP sensitized GBM to TMZ and suppressed TMZ-induced autophagy by negatively regulating ATG9B expression. A higher level of ATG9B expression was associated with GBM compared to low-grade glioma. The knockdown of ATG9B expression in GBM cells suppressed TMZ-induced autophagy as well as TMZ-resistance. Furthermore, we showed that DAB2IP negatively regulated ATG9B expression by blocking the Wnt/β-catenin pathway. To enhance the benefit of TMZ and avoid therapeutic resistance, effective combination strategies were tested using a small molecule inhibitor blocking the Wnt/β-catenin pathway in addition to TMZ. The combination treatment synergistically enhanced the efficacy of TMZ in GBM cells. In conclusion, the present study identified the mechanisms of TMZ-resistance of GBM mediated by DAB2IP and ATG9B which provides insight into a potential strategy to overcome TMZ chemo-resistance.

References Powered by Scopus

STAR: Ultrafast universal RNA-seq aligner

29828Citations
N/AReaders
Get full text

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

17408Citations
N/AReaders
Get full text

HTSeq-A Python framework to work with high-throughput sequencing data

14316Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.

183Citations
N/AReaders
Get full text

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma

128Citations
N/AReaders
Get full text

Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)

64Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yun, E. J., Kim, S., Hsieh, J. T., & Baek, S. T. (2020). Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma. Cell Death and Disease, 11(9). https://doi.org/10.1038/s41419-020-02988-8

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

57%

Researcher 7

33%

Lecturer / Post doc 2

10%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 14

50%

Agricultural and Biological Sciences 6

21%

Medicine and Dentistry 6

21%

Engineering 2

7%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free